Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/20739
Title: Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas’ disease treatment
Authors: Capriles, Priscila V. S. Z.
Guimarães, Ana C. R.
Otto, Thomas D.
Miranda, Antonio B.
Dardenne, Laurent E.
Degrave, Wim M.
Affilliation: Laboratório Nacional de Computação Científica, LNCC/MCT. Grupo de Modelagem Molecular de Sistemas Biológicos. Petrópolis, RJ, Brasil
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil / Parasite Genomics. Wellcome Trust Sanger Institute. Wellcome Trust Genome Campus. Cambridge, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Computacional e Sistemas. Rio de Janeiro, RJ. Brasil.
Laboratório Nacional de Computação Científica, LNCC/MCT. Grupo de Modelagem Molecular de Sistemas Biológicos. Petrópolis, RJ, Brasil
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Genômica Funcional e Bioinformática. Rio de Janeiro, RJ. Brasil.
Abstract: Background: Trypanosoma cruzi is the etiological agent of Chagas’ disease, an endemic infection that causes thousands of deaths every year in Latin America. Therapeutic options remain inefficient, demanding the search for new drugs and/or new molecular targets. Such efforts can focus on proteins that are specific to the parasite, but analogous enzymes and enzymes with a three-dimensional (3D) structure sufficiently different from the corresponding host proteins may represent equally interesting targets. In order to find these targets we used the workflows MHOLline and AnEnΠ obtaining 3D models from homologous, analogous and specific proteins of Trypanosoma cruzi versus Homo sapiens. Results: We applied genome wide comparative modelling techniques to obtain 3D models for 3,286 predicted proteins of T. cruzi. In combination with comparative genome analysis to Homo sapiens, we were able to identify a subset of 397 enzyme sequences, of which 356 are homologous, 3 analogous and 38 specific to the parasite. Conclusions: In this work, we present a set of 397 enzyme models of T. cruzi that can constitute potential structure-based drug targets to be investigated for the development of new strategies to fight Chagas’ disease. The strategies presented here support the concept of structural analysis in conjunction with protein functional analysis as an interesting computational methodology to detect potential targets for structure-based rational drug design. For example, 2,4-dienoyl-CoA reductase (EC 1.3.1.34) and triacylglycerol lipase (EC 3.1.1.3), classified as analogous proteins in relation to H. sapiens enzymes, were identified as new potential molecular targets.
Keywords: Trypanosoma cruzi
Chagas Disease
Drugs
Treatment
keywords: Trypanosoma cruzi
Doença de Chagas
Medicamentos
Tratamento
Issue Date: 2010
Publisher: BioMed Central
Citation: CAPRILES, Priscila V. S. Z. et al. Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for chagas’ disease treatment. BMC Genomics, v.11, n.610, 10, 2010.
DOI: 10.1186/1471-2164-11-610
ISSN: 1471-2164
Copyright: open access
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
ana_guimaraes_etal_IOC_2010.pdf3.08 MBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.